The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Thursday, 02 February 2017
Offering smokers a taster session at an NHS Stop Smoking Service and explaining their personal risk of developing smoking-related diseases doubles their likelihood of attending a stop smoking course.
Thursday, 02 February 2017
Liraglutide 1.2 mg has proved cost-effective when compared to alternative daily administered GLP-1 receptor agonists for the treatment of type 2 diabetes in the UK.
Topics covered:
Thursday, 02 February 2017
A new study shows that increased activity in the amygdala (the part of the brain involved in stress) is associated with a greater risk of heart disease and stroke. This study provides new insights into the possible mechanism by which stress can lead to cardiovascular disease in humans.
Topics covered:
Wednesday, 04 January 2017
A new study suggests that a ‘Sit Less’ intervention ‒ breaking sitting with standing and light-intensity walking ‒ may be an alternative to structured exercise to promote blood sugar control in patients with type 2 diabetes, giving improved 24-hour glucose levels and improved insulin sensitivity.
Topics covered:
Wednesday, 04 January 2017
Adding evolocumab to optimised statin therapy results in statistically significant regression of atherosclerosis in patients with coronary artery disease, according to results from the GLAGOV phase 3 trial.
Topics covered:
Wednesday, 04 January 2017
Tackling obesity by offering the opportunity to attend a weight loss programme during a routine consultation is effective, welcomed by patients and takes only 30 seconds, according to a new randomised trial of over 1800 people in the UK.
Topics covered:
Wednesday, 21 December 2016
Stroke related to atrial fibrillation can be prevented effectively through the use of anticoagulants. This article reviews recent guidelines, clinical trials and real-world evidence with non-vitamin K antagonist oral anticoagulants (NOACs) in patients with AF and provides practical guidance on the use of these newer agents in primary care.
Category: Editorial
Wednesday, 21 December 2016
‘Issues & Answers in Cardiovascular Disease’ is the leading UK cardiovascular conferences for the whole primary care team. Expert presenters and a down-to-earth approach help health professionals translate the latest evidence into daily practice and optimise patient care. Participants also receive 6 hours CPD credits. Read the highlights from the 2016 conference and access presentation slides here.
Category: Editorial
Monday, 19 December 2016
The UK charity Heart Valve Voice has developed the first practical guidance in heart valve disease for primary care. The disease is under-diagnosed and yet is increasing in prevalence as the population ages, so there is a need for primary care to plan an appropriate response.
Category: Editorial
Thursday, 24 November 2016
The large randomised controlled trial PARADIGM-HF showed that treatment with sacubitril/valsartan (Entresto) compared with enalapril reduced the risk of hospitalisation, cardiovascular and all-cause mortality and improved symptoms in patients with heart failure with reduced ejection fraction. This article describes the key results and how they can be applied in primary care.
Category: Editorial
Topics covered:

Article search and filter